on CaseMine. Advanced Infusion Solutions (AIS) Pharmaceutical Manufacturing Ridgeland, Mississippi 51 followers Follow View all 33 employees About us AIS HealthCare the leading provider of advanced sterile,. By continuing to use this website, you agree to UniCourts General Disclaimer, Terms of Service, Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, 2:21-cv-10076 Brought to you by the RECAP Initiative and Free Law Project, a non-profit dedicated to creating high quality open legal information. Denning v. Bond Pharmacy, Inc. - PacerMonitor In reviewing a motion under Federal Rule of Civil Procedure 12(b)(6), "the central issue is whether, in the light most favorable to the plaintiff, the complaint states a valid claim for relief." BOND PHARMACY INC. Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. Click on the case name to see the full text of the citing case. AIS Healthcare | LinkedIn 2:21-CV-12966 | 2021-12-20. The practitioner's primary taxonomy code is 3336H0001X with license number 04274/2.0 (MS). Plaintiff / Appellant: Randy Denning. February 7, 2022. AHS is a subsidiary of BCBS that maintains and operates BCBS provider networks in Mississippi. Closure of Advanced Pain Management facilities will - BizTimes 2009). [Previously dismissed case: No] [Possible companion case(s): None] (Moody, Nolan) (Entered: 01/11/2021). Advanced Infusion Solutions | Home Infusion Therapy Pharmacy in Id. Salaries below this are outliers. "The breach of good faith is bad faith characterized by some conduct which violates standards of decency, fairness or reasonableness." Phone: 601-988-1700. As of 01/01/2022 my insurance company was billed for and paid a part of a per diem of $120.00 . 18008 Bothell Everett Hwy SE # F, Bothell, WA 98012. 2018) (quoting Bus. The current location address for Advanced Infusion Solutions is 18451 Dallas Pkwy Ste 125, , Dallas, Texas and the contact number is 877-443-4006 and fax number is --. (LSau) (Entered: 04/06/2021), Docket(#10) NOTICE of Appearance by Paul Anthony Werner, III on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Id. Billing & Financial Support - AIS Healthcare The plausibility standard does not ask for a probability of unlawful conduct but does require more than a "sheer possibility." (Entered: 01/28/2021), (#5) NOTICE of Appearance by I. W. Winsten on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. BOND PHARMACY v. ADVANCED HEALTH SYSTEMS, INC. United States District Court, S.D. (877) 443-4006. ADVANCED INFUSION SOLUTIONS; NPI #1336243393 - NPIdb.org AIS sued BCBS and AHS, asserting breach of contract, breach of implied duty of good faith and fair dealing, unjust enrichment, breach of implied-in-fact contract, and failure to provide benefits under ERISA plans, and seeking declaratory judgment that it is entitled to payment. [59] at 16. Website: (LSau) (Entered: 02/18/2021), (#6) STIPULATION by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions (Winsten, I.) AIS Healthcare is proud to announce that its two state-of-the-art 503A compounding pharmacies (Ridgeland, Mississippi; Dallas, Texas) which produce patient-specific prescriptions for targeted drug delivery (TDD), and its five Advanced Infusion Care locations (Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; Dallas, Texas) have received the prestigious URAC . Date of service: 10/19/2021 via email - Attorney for Appellants: Burns, Camel, Richardson; Attorney for Appellees: Matini, Patron, Spencer-Davis, Werner [21-30534] (Roberta Louise Burns ) [Entered: 10/19/2021 02:16 PM], APPEARANCE FORM for the court's review. Id. Signed by District Judge Denise Page Hood. The Agreement's terms and conditions required AIS to submit a claim form that included a charge for home infusion therapy with the corresponding AHS-defined Healthcare Common Procedure Coding System ("HCPCS") procedure codes. Randy DENNING, PlaintiffAppellant, v. BOND PHARMACY, INCORPORATED, doing business as Advanced Infusion Care, doing business as Advanced Infusion Solutions, doing business as AIS Healthcare, DefendantAppellee. [21-30534] (SEP) [Entered: 09/24/2021 08:54 AM], TRANSCRIPT ORDER received from Appellant Mr. Randy Denning advising transcript unnecessary as it is already filed. Contact - AIS Healthcare 27-29, 37, and establishes the remaining elements with particularity, see id. We engage with your physician to offer the highest standard of care. No. (Entered: 03/04/2021), Docket(#7) ORDER for Extension of Time to Respond to Complaint #1 , ( Response due by 3/4/2021) Signed by District Judge Denise Page Hood. 17. [21-30534] (Timothy Richardson ) [Entered: 09/14/2021 09:49 AM], APPEARANCE FORM for the court's review. Our reports cover every category imaginable! Access this case on the Michigan Eastern District Court's Electronic Court Filings (ECF) System. BCBS and AHS seek declaratory judgment, asking the Court to declare that BCBS has no contractual obligation to pay the alleged unpaid, mispresented claims. Infusion Solutions allows patients to utilize our state-of-the-art Private Infusion Suites for all their intravenous (IV) therapy needs. Redacted Transcript Deadline set for 8/6/2021. 3:11 . [21-30534] (Charles H. Spencer-Davis ) [Entered: 09/13/2021 04:12 PM], APPEARANCE FORM FILED by Attorney(s) Imad Sayed Matini for party(s) Appellee Bond Pharmacy, Incorporated, in case 21-30534. Spokeo, 578 U.S. at 340-41). (dba The Wellness Pharmacy), Winchester, VA- 503A Facility, Kalman Health & Wellness, Inc. (dba Essential Wellness Pharma), Peoria, IL- 503A Facility, Kelley-Ross Compounding Pharmacy, Seattle, WA- 503A Facility, Key Compounding Pharmacy (see Puget Sound Drug Corporation), Federal Way, WA- 503A Facility, Keystone Pharmacy, Grand Rapids, MI- 503A Facility, Keystone Rx LLC, Bensalem, PA- 503A Facility, Kings Park Slope, Inc., Brooklyn, NY- 503A Facility - De-registered as an Outsourcing Facility, Kohana Pharmacy and Center for Regenerative Medicine Inc., San Luis Obispo, CA- 503A Facility, Kohll's Compounding, Omaha, NE- 503A Facility, Kona Community Hospital Pharmacy, (see Hawaii Health Systems Corporation), Kealakekua, HI- 503A Facility, KRS Global Biotechnology, Inc. Boca Raton, FL- 503B Facility, Ladd Family Pharmacy LLC, Boise, ID- 503A Facility, Lato Drug Company, Inc. (dba Post Haste Pharmacy), Hollywood, FL- 503A Facility, La Vita Compounding Pharmacy, LLC, San Diego, CA- 503A Facility, Lee and Company (dba Lee Pharmacy, Inc.), Fort Smith, AR- 503A Facility - Out of business, Lee Pharmacy, Inc.(see Lee and Company), Fort Smith, AR- 503A Facility, LeeSar, Inc., Fort Myers, FL- 503B Facility, Lee Silsby Compounding Pharmacy, (see Gipsco Investment Corp.), Cleveland Heights, OH- 503A Facility, Leiter's Cambrian Park Drugs, Inc., (dbaLeiter's Compounding Pharmacy), 1700 Park Avenue, San Jose, CA- 503A Facility - Out of business, Leiter's Compounding, 17 Great Oaks Blvd., San Jose, CA- 503A Facility, Leiter's Compounding Pharmacy,(see Leiter's Cambrian Park Drugs, Inc.), San Jose, CA- 503A Facility, Leiter's Health, (see Denver Solutions, LLC), Englewood, CO- 503A Facility, Liberty Drug and Surgical, Chatham, NJ- 503A Facility, Life Science Pharmacy, Inc., Harriman, NY- 503A Facility, Lifetime Value Pharmacy III Inc., Santa Ana, CA- 503A Facility, Lincare, Inc. (dba United Medical Home Infusion), Little Rock, AR- 503A Facility, Lloyd Central Compounding Pharmacy, (see Portland Compounding Pharmacy, LLC), Portland, OR- 503A Facility, Loop Pharmacy & Home Medical, Saint Albans, WV- 503A Facility, Louisville Pharmacy (see Spoonamore Drug Co., Inc.), Louisville, KY- 503A Facility, Lowlite Investments, Inc. (dba Olympia Pharmacy), Orlando, FL- 503A Facility, Lowlyn Pharmacies, Inc. (dba Red Cross Drug), Blanchard, OK- 503A Facility, Lynnfield Drug, Inc. (dba Freedom Fertility Pharmacy), Byfield, MA- 503A Facility, Lynn Oaks Compounding Pharmacy, Thousand Oaks, CA - 503A Facility, M Drug, LLC, (dba Northern Light Pharmacy), Bangor, ME- 503A Facility, Maag Prescription Center LLC, Pocatello, ID- 503A Facility, Madison Drugs (see Service First Pharmacies, Inc.), Huntsville, AL- 503A Facility, Magellan Rx Pharmacy LLC, Astoria, NY- 503A Facility, Maimonides Medical Center-Pharmacy, Brooklyn, NY- 503A Facility, Main Street Family Pharmacy, Newbern, TN- 503A Facility - Out of business, Maitland Labs of Central Florida, Orlando, FL- 503A Facility - Out of business, Malley's Compounding Pharmacy, (see Columbia River Pharmacy, LLC), Richland, WA- 503A Facility, Malanda, Inc., (dba Mandell's Clinical Pharmacy), Somerset, NJ- 503A Facility, Maplerose Enterprises, LLC (dba Pencol Pharmacy), Denver, CO- 503A Facility, Mark Drugs Pharmacy, (see Snyder Mark Drugs Roselle, Inc.), Roselle, IL- 503A Facility, Martin Avenue Pharmacy, Inc., Naperville, IL- 503A Facility, Maryland Specialty and Compounding, LLC dba Professional Arts Pharmacy, Baltimore, MD- 503A Facility - Ceased sterile compounding, MasterPharm LLC. Infusion Solutions, LLC, was founded in 2020 by Annette Bennett and Lucien Roberts. (Werner, Paul) (Entered: 03/11/2021), (#9) MOTION for Default Judgment as to Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions by Blue Cross Blue Shield of Michigan. vitamine pentru pofta de mancare si ingrasare copii. Advanced Infusion Services | LinkedIn Motion Hearing set for 6/23/2021 04:00 PM before District Judge Denise Page Hood |Zoom Webinar Information: https://www.zoomgov.com/j/1616326086?pwd=dTVZRnlseVBTNFRhNVE0SlhQaEozUT09 Passcode: 999999 Or One tap mobile : US: +16692545252,,1616326086# or +16468287666,,1616326086#| (LSau) (Entered: 05/11/2021), (#22) NOTICE of Appearance by Kevin M. Cloutier on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Lists Featuring This Company Texas Health Care Companies (Top 10K) 9,875 Number of Organizations $24.7B Total Funding Amount 1,718 Number of Investors Track Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, Attorney at Sheppard Mullin Richter & Hampton, LLP, Attorney at Sheppard, Mullin, Richter & Hampton LLp, Attorney at Sheppard Mullin Richter and Hampton, LLP, Attorney at Sheppard Mullin Richter & Hampton LLP, Exhibit 3 - October 16, 2020 Letter from P. Werner to M. Martinez, Exhibit 2 - October 6, 2020 Letter from M. Martinez to J. Finley, Docket(#25) TRANSCRIPT of Hearing on Defendant's Motion to Dismiss held on 06/23/2021. See AIS's Memo. 1:22-CV-00542 | 2022-06-13, U.S. District Courts | Civil Right | Physical address: Carr. BOND PHARMACY d/b/a, ADVANCED INFUSION SOLUTIONS Plaintiff, For the following reasons, the Court denies the motion. 2005) (citation omitted). Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017.